Medical Affairs AI Best Practices
Operational excellence is built on the consistent application of proven standards. Let’s ensure your team operates with the precision and uniformity required to drive sustained business impact.
“Be a yardstick of quality. Some people aren’t used to an environment where excellence is expected.” Steve Jobs (Founder of Apple)
Show Me the Proof: Measuring ROI of AI in Medical Affairs
Paul Minne, PharmD, April 7, 2026
A big question facing every pharmaceutical and biotech executive today is how Medical Affairs (MA) can demonstrate a measurable return on investment (ROI) for artificial intelligence. While commercial teams rely on prescription sales data, MA operates under strict firewalls that make these metrics inapplicable if not illegal. Furthermore, traditional reliance on proxy metrics, such as KOL visit volume or subjective time saved surveys, is insufficient for a modernized, AI savvy organization.
Meaningful ROI measurement for AI in MA must move past aspirational value and focus precisely on operational velocity and strategy execution. Effective AI deployment must demonstrate that operations are moving faster, making a positive impact, and achieving strategic imperatives. To build a defensible business case, organizations should prioritize quantifying core areas where agentic AI actively delivers measurable ROI today.
Three specific “low-hanging fruit” areas offer immediate opportunities for measuring this operational impact:
- Strategic Impact: Measure how quickly a predefined strategic objective accelerates a validated intelligence trend and the KOL sentiment around it.
- Resource Lifecycle Speed: The precise reduction in days required to move new or updated content from idea to approval.
- KOL Knowledge Shift: Moving beyond raw volume metrics to focus on team level influence and aggregate changes in scientific discourse. In other words, ROI can be determined by measuring how fast the scientific platform sticks with KOLs.
Success belongs to organizations that move past treating AI as an email editor and instead implement precise ROI measurements.
Beyond Google: A Blueprint for Grounded AI in Medical Affairs
Paul Minne, PharmD, April 1, 2026
If your Medical Affairs (MA) team is still treating artificial intelligence primarily as an exceptionally fast, albeit occasionally confused, search engine, you are already behind. Untrained models can quickly summarize an abstract or rewrite an email, but this utility is merely tactical. Real modernization requires a shift to grounded, agentic intelligence, which are tools that do not just summarize data but synthesize it with scientific context.
This integration demands an operational foundation built around Retrieval Augmented Generation (RAG) architecture. RAG ensures that your AI is not just searching the generic web. Instead, it pulls specifically from your verified repositories: MSL field notes, Medical Information databases, ClinicalTrials.gov, and your internal publications library. This structure minimizes hallucinations and provides the ability to trace every AI generated insight directly back to its source. The gap between a novelty tool and a strategic asset is this grounded truth.
Moving past the tactical search and summarize trap requires high value operational optimization in high volume areas. This will eventually lead to a shift to proactive autonomous medical agents. Success in 2026 belongs to those who stop treating AI as a fast Google and instead build necessary guardrails and invest in the data hygiene required for grounded, agentic workflows.
Read the full article and the blueprint steps here…
Why Most Medical Affairs AI Rollouts Fail
Paul Minne, PharmD, March 5, 2026
The gold rush is on. Across the pharmaceutical landscape, Medical Affairs organizations are sprinting to deploy artificial intelligence. On paper, the promise of automated insight generation and superhuman MSL efficiency is intoxicating. Yet, the data tells a sobering story. A staggering majority of AI initiatives fail to move beyond the pilot phase or become shelf-ware that the field team actively avoids.
The failure is strategic, not technical. We often treat AI as a technical patch for a structural problem.
The most common reason for failure is the garbage in, garbage out principle. Many organizations assume AI is a magical layer that can make sense of unstructured, messy data. It cannot. If your field notes are inconsistent and your databases are siloed, your rollout will fail. Most teams spend 90% of their budget on the tool and 10% on data hygiene. It should be the other way around.
Secondly, most rollouts fail because they solve for tasks rather than business outcomes. Summarizing abstracts or drafting emails are nice efficiencies, but they do not move the needle on excellence. Real modernization occurs when you plan for outcomes, such as reducing the time from congress insight to strategic pivot. If you cannot measure insight velocity, the speed at which your organization moves from a data point to action, the rollout is just an expensive window dressing.
Lastly, the human in the loop fallacy creates a massive friction point. We hire experts for their critical thinking, then expect them to trust magic box logic implicitly. If we do not feel like we are flying the plane, we will let the autopilot fly it into the ground while we return to our trusted analog Art of MSLing ways. Success in 2026 belongs to those who treat AI as a megaphone for medical expertise, not a replacement for it.
Is AI Flying the Plane as You Build It?
By Paul Minne, PharmD, February 24, 2026
If you spent 2025 using AI to rewrite emails to Clinical Ops, you weren’t alone. But as we settle into 2026, the honeymoon phase is over. Leadership doesn’t want a shiny new interface; they want modernization. The reality of the AI transition is realizing that we have spent millions on high-tech intelligence only to find it has the situational awareness of a golden retriever in a room full of tennis balls. It is fast and enthusiastic, but it is going to knock over a few expensive lamps if you do not keep it on a leash.
The number one focus for Medical Affairs today is not the model, but the context. An AI agent that summarizes a forty-page publication in ten seconds is impressive. An agent that tells you why that publication matters to your specific launch strategy, your MSL field insights, and your upcoming PDUFA date is a unicorn.
Most organizations are currently drowning in correct data that is strategically useless. We have moved from the era of Big Data to the era of Big Distraction. If your tools are churning out summaries that do not explain what this means for KOL engagement next week, you are just making the noise louder. You are building a faster assembly line for digital clutter that your team will never actually use.
We are pivoting toward Agentic AI: systems designed to observe, plan, and act. But an agent without context is an automated error generator. Think of yourself as the Human in the Cockpit. AI is the autopilot, fantastic for maintaining altitude and handling repetitive tasks. But when the weather gets rough such as when a competitor drops a surprise data set or a regulatory agency moves the goalposts, you need a pilot who understands how to navigate around the weather. Stop treating AI as a tool for endless analysis and start using it as a catalyst for action. Modernization is not about replacing humans. It is about giving us a better set of flight instruments. Just make sure the person in the captain’s chair knows which direction the horizon is.
Is Medical Affairs Next?
By Paul Minne, PharmD, February 23, 2026
As the corporate landscape shifts toward mandatory AI integration, Medical Affairs stands at a critical crossroads. Recent mandates from global giants like Accenture and Microsoft signal a new reality where AI proficiency is no longer a professional elective but a requirement for leadership and career advancement.
The cost of inaction is high. Teams that resist adoption risk insight decay, where the overwhelming volume of scientific data outpaces human processing capabilities. Without these tools, Medical Affairs risks losing its strategic edge, falling behind in excellence and eroding its credibility with senior leadership. Moving forward, the value of the MSL and Medical Director shifts from manual data synthesis to high-level strategic editing.
This evolution requires a proactive approach. By establishing governed, human-led AI workflows now, medical leaders can ensure they remain the architects of their strategy rather than being forced into reactive compliance. The future of Medical Affairs belongs to those who leverage technology to amplify their scientific expertise, ensuring they remain an indispensable valued driver in a digital-first industry.
Common Mistakes I See When Medical Affairs Implements AI
By Paul Minne, PharmD, February 19, 2026
In my work consulting with biotech and pharma teams, I’m seeing a recurring pattern. As organizations scramble to modernize, they often treat AI like a plug-and-play software update rather than a fundamental shift in scientific strategy.
While the potential for efficiency and field medical excellence is massive, the execution often falters. Here are the most common mistakes I see Medical Affairs making when implementing AI and how to steer clear of them.
The “Zero to 100” Sprint
The most frequent error is attempting to go from zero to 100 immediately. Organizations often try to automate massive, end-to-end medical strategies overnight, skipping the necessary pilot phases and foundational data maturity. This “all-or-nothing” approach usually leads to pilot fatigue and systems that crash under the weight of unrealistic expectations. Sustainable modernization requires building a solid base before pushing for full-scale automation.
Asking AI to be the Architect, Not the Inspector
I see many teams making the mistake of having AI write the strategy. This is a fundamental misunderstanding of the technology.
Humans, the PhDs, MDs, and PharmDs with deep therapeutic expertise, must do the heavy lifting of thinking, ideation, and strategy creation. AI’s highest and best use is as an inspector. Use it to stress-test your human led strategy. Have it find the “holes,” identify missed data points, or surface contradictory insights from months of MSL field notes. Make the humans provide the vision, allow the AI to find the gaps.
Operating in a Context Vacuum
AI is technically smart but contextually blind. A common pitfall is deploying AI tools without clearly defining the “Why.” If the humans don’t provide the context of what specific problem they are solving and for what purpose, the AI will provide technically correct but strategically useless outputs. AI needs a pilot to tell it which direction the ship is heading; otherwise, you’re just generating noise at scale.
Treating Compliance as a Finish Line, not a Guardrail
One of the most avoidable mistakes is keeping Legal and Compliance in the dark until the final reveal. If you treat legal review as a hurdle to clear at the end of a project, you risk having months of work vetoed in an afternoon. Instead, get them on board on day one. Frame AI adoption as a way to strengthen compliance through better traceability and reduced manual error. When Legal understands the “human-in-the-loop” safeguards you’ve built, they stop seeing AI as a liability and start seeing it as a tool for risk mitigation.
The “IT Led” Disconnect
When AI adoption is driven solely by the IT department without deep input from Medical, the result is a tool that is technically sound but potentially scientifically clunky. These tools often lack the nuance required for high-level HCP engagement. To showcase impact that sticks with senior leadership, Medical must lead the functional design, with IT providing the technical scaffolding.
Ignoring the Trust Gap
Finally, we cannot ignore the human element. If your MSLs feel like AI is replacing their expertise rather than augmenting it, adoption will stall. We must prepare our teams for the shift from author to editor. Our value isn’t in the manual labor of summarizing a paper; it’s in the strategic application of that information to drive excellence.
The Bottom Line: AI should make your impact more visible and your workflows more efficient, but it cannot replace human intuition and medical expertise.
Beyond GenAI: How Agentic AI is Revolutionizing Medical Affairs
By Paul Minne, PharmD, February 17, 2026
Medical affairs teams are currently facing a massive challenge: an explosion of healthcare data combined with increasing pressure to prove their strategic value to the C-suite. While standard Large Language Models offer speed, they often struggle with hallucinations and bias, risks that are unacceptable when patient safety is on the line.
According to a recent article by Vic Ho and Seth Tyree in MedCity News (January 2026), the solution lies in Agentic AI. Unlike general-purpose models that generate a single response, Agentic AI employs a team of specialized agents working in concert. Individual agents handle specific tasks such as literature monitoring, source verification, or compliance review before combining their findings into a single, validated output.
This approach offers critical advantages over standard AI:
• Enhanced Accuracy: Specialized agents cross-check information against verified sources like ClinicalTrials.gov, ensuring claims are traceable and trustworthy.
• Bias Reduction: By validating across multiple datasets, Agentic AI contextualizes outliers, preventing anecdotal evidence from skewing medical decisions.
• Personalization: It moves beyond simple summaries to explain why trends are happening, tailoring the output for different audiences, from peer-to-peer discussions to patient-facing materials.
Ultimately, this technology is not about replacing human experts. Agentic AI amplifies medical professionals. By handling the heavy lifting of validation and contextualization in the background, it frees Medical Science Liaisons to focus on what matters most: improving patient outcomes through evidence-based care.
Stop Artificial Intelligence from being a “yes man”
By Paul Minne, PharmD, February 10, 2026
Does AI sometimes respond to your request with “That is such an amazing creative idea!”. Many users express frustration with the AI’s default tendency to provide excessive validation, even when a human’s logic or decision-making is clearly flawed. The good news is there is a fix to make AI avoid unnecessary flattery. Combat AI sycophancy by using custom instructions to make any AI more critical and objective. Enter these system rules into your user settings (sometime under “user preferences” or “custom instructions” depending on the agent used) which are designed to encourage honest pushback, directness, and the identification of errors.
Example rules to enter:
- Stop excessive validation
- Challenge my reasoning
- Assume there are 3 major errors in what I am requesting
- Avoid flattery and unnecessary praise
- Be antisycophantic
- Don’t close arguments just because I push back
While most find these adjustments improve the quality of responses, take some caution that being too aggressive can occasionally turn the AI into an unhelpful contrarian. You want to balance AI so that it acts as a rigorous thinking partner without providing unrealistic timelines, analysis, and suggestions. Overall, tailoring user preferences is essential for transforming the AI from a mere “yes-man” into a valuable analytical tool.
Medical Affairs should automate routine tasks today!
By Paul Minne, PharmD, February 3, 2026
One of the easiest and quickest ways to digitally transform medical affairs is to automate routine tasks such as responding to medical inquiries and synthesizing vast amounts of clinical data. Beyond mere operational fixes, let AI act as a strategic partner that identifies key opinion leaders, uncovers real-world evidence, and personalizes engagement with healthcare stakeholders.
Can Field Medical Affairs alone increase operating margin? Of course!
By Paul Minne, PharmD, January 23, 2026
To emphasize a multichannel approach to insight sharing, ensure that critical medical information is distributed across organizations to improve patient outcomes. Ethical standards and human empathy is vital to prevent technology from depersonalizing professional relationships. Ultimately, the transition to AI-enhanced medical affairs requires a robust governance framework to balance innovation with compliance and accuracy.
